Explore how multi-angle light scattering enhances biosimilar analysis by delivering accurate molecular weight and size ...
The majority of human illnesses is caused by damage of a single organ like the liver whose failure accounts for 2M deaths worldwide every year. Orthotopic transplants are the only curative therapy ...
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...
The Coalition for Epidemic Preparedness Innovations (CEPI) announced earlier today that the University of Oxford has entered ...
An overview of how specialty laboratories use integrated scientific approaches to deliver high-quality infectious disease ...
The Print on MSN
India’s first dengue vaccine has been in the making for 17 yrs. DengiAll has the world excited
At the Panacea Biotec office, conversations around DengiAll are cloaked with an air of eagerness. With the human trials ...
Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. today appointed two obstetricians-gynecologists to the ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback